Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
archive
medical
research
fda
biotech
boehringer ingelheim
clinical trials
eli lilly
empagliflozin
europe
europe blog main
europe top stories
indiana blog main
indiana top stories
life sciences
national blog main
new york blog main
new york top stories
recalls
slgt2 inhibitor
study
type 1 diabetes
type 2 diabetes
What
diabetes
5
×
drug
5
×
type
5
×
blood
popular
risk
treat
used
called
diabetics
disease
failure
fda
study
sugar
alzheimer’s
announced
approval
bid
boehringer
canagliflozin
cancer
catch
caused
come
common
decreased
dementia
developing
drastically
effective
eli
empagliflozin
expand
fallen
findings
finds
heart
impurity
individuals
Language
unset
Current search:
type
×
drug
×
diabetes
×
@slashgear.com
3 years ago
Popular diabetes drug recalled months after FDA issued cancer risk warning
@slashgear.com
3 years ago
Another study finds metformin lowers dementia risk, but there’s a catch
@xconomy.com
4 years ago
FDA Rejects Boehringer Ingelheim, Eli Lilly Drug for Type 1 Diabetes
@slashgear.com
5 years ago
Common blood sugar drug found to reverse heart failure in non-diabetics
@slashgear.com
5 years ago
Popular blood sugar drug slashes kidney failure risk in diabetics